Local tumor destruction by photodynamic therapy induces potent antitumor T-cell responses, which can be enhanced by systemic CTLA-4 blockade to eliminate local and distant tumors in mice. This provides an alternative approach to treating advanced multifocal cancer. 
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CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells
Mireya Paulina Velasquez, Arpad Szoor, Abishek Vaidya, Aarohi Thakkar, Phuong Nguyen, Meng-Fen Wu, Hao Liu, and Stephen Gottschalk T cells expressing a bispecific linker coupling tumor-expressed CD19 to CD3 were more effective when also expressing CD80 and 41BBL costimulatory molecules. Such T cells had increased IFNg and IL2 production and enhanced antitumor activity in mouse models.
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Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC Natasha K. Brockwell, Katie L. Owen, Damien Zanker, Alex Spurling, Jai Rautela, Hendrika M. Duivenvoorden, Nikola Baschuk, Franco Caramia, Sherene Loi, Phillip K. Darcy, Elgene Lim, and Belinda S. Parker Combination therapy exploiting the interplay between type I IFN signaling and the PD-1/PD-L1 axis induced a tumorspecific cytotoxic response in mouse models of triple-negative breast cancer, extending survival specifically in the neoadjuvant setting. 
ABOUT THE COVER
Human papilloma virus (HPV) is associated with several malignancies, especially cervical and head and neck cancers. Vaccines are being used to treat various cancers, but with limited success. Atherton et al. demonstrate a promising approach that may provide more consistent antitumor responses. They infected mice with the oncolytic Maraba virus, which selectively infects and lyses tumor cells, while also acting as a vaccine, based on attenuated HPV E6 and E7 transforming proteins. Antigen-specific CD8 þ T cells were activated, HPV þ tumors eradicated, and memory induced. This one-two punch strategy may overcome the immunosuppression of advanced disease. Read more in this issue starting on page 847. The micrograph is a hematoxylin-eosin stain of a TC1 tumor harvested from a vaccine-treated mouse. Artwork by Lewis Long.
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